Transform your data management, informatics systems utilisation and R&D processes.

November 16-17, 2021 | USA

The global laboratory informatics market is forecast to reach $3.8bn by 2024, with the growth driven primarily by the enhanced importance of data analytics for drug discovery, increasing regulatory requirements and the greater utilization of automation in the lab. However, the primary challenge to realizing the potential of lab informatics remains the ability to not only effectively structure and integrate disparate data sources. 

Spotlight

This report sets out the key challenges, risks and opportunities associated with establishing a national medicinal cannabis scheme in Australia. The report is comprised of several sections, each intended to serve as a reference for future policy discussions in the Australian medicinal cannabis industry. Section 2 begins by discussing the medicinal and scientific aspects of the debate, specifically addressing the evidence supporting medicinal cannabis treatments for various conditions. Section 3 then examines how medicinal cannabis regulation has been approached internationally, in addition to exploring recent developments and expected challenges for Australia. Section 4 develops two methodological approaches for estimating the potential domestic demand for medicinal cannabis in Australia.


OTHER PAST CONFERENCES

WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

September 18-August 22, 2022 | Spain

At this critical time, when the challenges presented by the COVID-19 pandemic are still current and on the minds of healthcare professionals, we must take the opportunity to create more comprehensive plans to better manage health crises that may be on the horizon.

World Congress on Advanced Pharmacy and Clinical Research (WCADPHCLRE)

September 7, 2022 | Kuwait

World Congress on Advanced Pharmacy and Clinical Research (WCADPHCLRE)

Temperature Controlled Logistics And Security

September 20-22, 2022 | USA

We are the world’s most innovative and educational event covering all you need to know about optimizing your end-to-end supply chain from a patient-centric, regulatory-compliant and cost effective perspective.

TRANSPARENCY AGGREGATE SPEND & HCP ENGAGEMENT

August 9-11, 2022 | USA

Transparency, Aggregate Spend & HCP Engagement is your best opportunity to convene with like-minded professionals working within the world of Life Sciences within compliance and legal departments.

Spotlight

This report sets out the key challenges, risks and opportunities associated with establishing a national medicinal cannabis scheme in Australia. The report is comprised of several sections, each intended to serve as a reference for future policy discussions in the Australian medicinal cannabis industry. Section 2 begins by discussing the medicinal and scientific aspects of the debate, specifically addressing the evidence supporting medicinal cannabis treatments for various conditions. Section 3 then examines how medicinal cannabis regulation has been approached internationally, in addition to exploring recent developments and expected challenges for Australia. Section 4 develops two methodological approaches for estimating the potential domestic demand for medicinal cannabis in Australia.

resources